Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Kyobu Geka. the Japanese Journal of Thoracic Surgery|September 4, 2020
[Experience with Pulmonary Resection under Thoracoscopic Surgery for Lung Cancer Patient with Abnormal Left A4b+5 and A8+9 Branching]Shunsuke Eba, Masaki Shimoji, Masahide Hirose, et al.Kyobu Geka. the Japanese Journal of Thoracic Surgery|May 13, 2020
[Schloffer Tumor that Appeared and Increased 40 Months after Resection of Lung Cancer and was Suspected of Recurrence of Pleural Dissemination]Shunsuke Eba, Masaki Shimoji, Masahide Hirose, et al.Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Clinical and pathologic features of lung cancer expressing programmed cell death ligand 1 (PD-L1)Masaki Shimoji, Shigeki Shimizu, Katsuaki Sato, et al.Clinical Lung Cancer|November 9, 2021
Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung CancerKenichi Suda, Shuta Ohara, Toshio Fujino, et al.Cancer Science|February 3, 2012
Small non-mucinous bronchioloalveolar carcinoma with anaplastic lymphoma kinase immunoreactivity: a novel ALK fusion gene?Morio Yamamoto, Kengo Takeuchi, Masaki Shimoji, et al.Biomolecules|September 11, 2019
Comparison of PD-L1 Expression Status between Pure-Solid Versus Part-Solid Lung AdenocarcinomasKenichi Suda, Masaki Shimoji, Shigeki Shimizu, et al.Surgical Case Reports|February 28, 2024
A case of late-onset bleeding from an intercostal artery pseudoaneurysm after hemostasis using soft coagulationRie Shimizu, Kenichi Suda, Toshiki Takemoto, et al.Thoracic Cancer|September 20, 2024
Clinical factors associated with high PD-L1 expression in patients with early-stage non-small cell lung cancerShuta Ohara, Kenichi Suda, Akira Hamada, et al.Journal of Hematology & Oncology|June 11, 2022
Foretinib can overcome common on-target resistance mutations after capmatinib/tepotinib treatment in NSCLCs with MET exon 14 skipping mutationToshio Fujino, Kenichi Suda, Takamasa Koga, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 4, 2016
Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR MutationKenichi Suda, Isao Murakami, Hui Yu, et al.Pageof 4